Tandem Diabetes Care (NSDQ:TNDM) last week launched its t:slim X2 insulin pump with Basal-IQ technology in the U.S.
The company’s latest pump includes a predictive low glucose suspend feature designed to reduce the frequency and duration of hypoglycemia.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem launches insulin pump with predictive low glucose suspend feature in US appeared first on MassDevice.